147 related articles for article (PubMed ID: 37195391)
1. Molecular docking and dynamic simulations of quinoxaline 1,4-di-N-oxide as inhibitors for targets from Trypanosoma cruzi, Trichomonas vaginalis, and Fasciola hepatica.
González-González A; Méndez-Álvarez D; Vázquez-Jiménez LK; Delgado-Maldonado T; Ortiz-Pérez E; Paz-González AD; Bandyopadhyay D; Rivera G
J Mol Model; 2023 May; 29(6):180. PubMed ID: 37195391
[TBL] [Abstract][Full Text] [Related]
2. Phenothiazine-based virtual screening, molecular docking, and molecular dynamics of new trypanothione reductase inhibitors of Trypanosoma cruzi.
González-González A; Vázquez C; Encalada R; Saavedra E; Vázquez-Jiménez LK; Ortiz-Pérez E; Bolognesi ML; Rivera G
Mol Inform; 2023 Oct; 42(10):e2300069. PubMed ID: 37490403
[TBL] [Abstract][Full Text] [Related]
3. Esters of quinoxaline-7-carboxylate-1,4-di-
Palos I; Moo-Puc R; Vique-Sánchez JL; Benítez-Cardoza CG; Monge A; Villalobos-Rocha JC; Paz-Gonzalez AD; Rivera G
Acta Pharm; 2021 Sep; 71(3):485-495. PubMed ID: 36654088
[TBL] [Abstract][Full Text] [Related]
4. In Vitro and In Silico Analysis of New n-Butyl and Isobutyl Quinoxaline-7-carboxylate 1,4-di-
González-González A; Sánchez-Sánchez O; Krauth-Siegel RL; Bolognesi ML; Gớmez-Escobedo R; Nogueda-Torres B; Vázquez-Jiménez LK; Saavedra E; Encalada R; Espinoza-Hicks JC; Paz-González AD; Rivera G
Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362102
[TBL] [Abstract][Full Text] [Related]
5. Trypanocidal Activity of Quinoxaline 1,4 Di-N-oxide Derivatives as Trypanothione Reductase Inhibitors.
Chacón-Vargas KF; Nogueda-Torres B; Sánchez-Torres LE; Suarez-Contreras E; Villalobos-Rocha JC; Torres-Martinez Y; Lara-Ramirez EE; Fiorani G; Krauth-Siegel RL; Bolognesi ML; Monge A; Rivera G
Molecules; 2017 Feb; 22(2):. PubMed ID: 28157150
[TBL] [Abstract][Full Text] [Related]
6. Anti-Trypanosoma cruzi and anti-leishmanial activity by quinoxaline-7-carboxylate 1,4-di-N-oxide derivatives.
Villalobos-Rocha JC; Sánchez-Torres L; Nogueda-Torres B; Segura-Cabrera A; García-Pérez CA; Bocanegra-García V; Palos I; Monge A; Rivera G
Parasitol Res; 2014 Jun; 113(6):2027-35. PubMed ID: 24691716
[TBL] [Abstract][Full Text] [Related]
7. Ligand-Based Virtual Screening and Molecular Docking of Benzimidazoles as Potential Inhibitors of Triosephosphate Isomerase Identified New Trypanocidal Agents.
Vázquez-Jiménez LK; Juárez-Saldivar A; Gómez-Escobedo R; Delgado-Maldonado T; Méndez-Álvarez D; Palos I; Bandyopadhyay D; Gaona-Lopez C; Ortiz-Pérez E; Nogueda-Torres B; Ramírez-Moreno E; Rivera G
Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077439
[No Abstract] [Full Text] [Related]
8. Triosephosphate isomerase as a therapeutic target against trichomoniasis.
Benítez-Cardoza CG; Brieba LG; Arroyo R; Rojo-Domínguez A; Vique-Sánchez JL
Mol Biochem Parasitol; 2021 Nov; 246():111413. PubMed ID: 34537286
[TBL] [Abstract][Full Text] [Related]
9. Cathepsin L Inhibitors with Activity against the Liver Fluke Identified From a Focus Library of Quinoxaline 1,4-di-
Ferraro F; Merlino A; Gil J; Cerecetto H; Corvo I; Cabrera M
Molecules; 2019 Jun; 24(13):. PubMed ID: 31247891
[TBL] [Abstract][Full Text] [Related]
10. Quinoxaline 1,4-di-N-Oxide Derivatives: Are They Unselective or Selective Inhibitors?
Rivera G
Mini Rev Med Chem; 2022; 22(1):15-25. PubMed ID: 33573542
[TBL] [Abstract][Full Text] [Related]
11. Flavonoid-quinoxaline Hybrid Compounds as Cathepsin Inhibitors Against Fascioliasis.
Ferraro F; Merlino A; Gil J; Pérez-Silanes S; Corvo I; Cabrera M
ChemMedChem; 2024 Jun; ():e202400305. PubMed ID: 38871654
[TBL] [Abstract][Full Text] [Related]
12. Molecular docking and molecular dynamics simulation studies of Trypanosoma cruzi triosephosphate isomerase inhibitors. Insights into the inhibition mechanism and selectivity.
Minini L; Álvarez G; González M; Cerecetto H; Merlino A
J Mol Graph Model; 2015 May; 58():40-9. PubMed ID: 25829097
[TBL] [Abstract][Full Text] [Related]
13. Structural analysis and molecular docking of trypanocidal aryloxy-quinones in trypanothione and glutathione reductases: a comparison with biochemical data.
Vera B; Vázquez K; Mascayano C; Tapia RA; Espinosa V; Soto-Delgado J; Salas CO; Paulino M
J Biomol Struct Dyn; 2017 Jun; 35(8):1785-1803. PubMed ID: 27232454
[TBL] [Abstract][Full Text] [Related]
14. Developing a new drug against trichomoniasis, new inhibitory compounds of the protein triosephosphate isomerase.
Vique-Sánchez JL; Caro-Gómez LA; Brieba LG; Benítez-Cardoza CG
Parasitol Int; 2020 Jun; 76():102086. PubMed ID: 32112829
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the effect of methyl 2-acetamide-3-methylquinoxaline-7-carboxylate 1,4-di-N-oxide on the relative expression of the trypanothione reductase gene in Trypanosoma cruzi epimastigotes.
Vazquez-Jimenez LKK; Hernandez-Posada MI; Paz-Gonzalez AD; Nogueda-Torres B; Martinez-Vazquez AV; Herrera-Mayorga V; Bocanegra-Garcia V; Rivera GR
Pak J Pharm Sci; 2019 May; 32(3 Special):1447-1452. PubMed ID: 31551230
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and trypanocidal activity of novel benzimidazole derivatives.
Velázquez-López JM; Hernández-Campos A; Yépez-Mulia L; Téllez-Valencia A; Flores-Carrillo P; Nieto-Meneses R; Castillo R
Bioorg Med Chem Lett; 2016 Sep; 26(17):4377-81. PubMed ID: 27503677
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and antiparasitic properties of new 4-N-benzylamino-4-hetarylbut-1-enes.
Kouznetsov VV; Castro JR; Puentes CO; Stashenko EE; Martínez JR; Ochoa C; Pereira DM; Ruiz JJ; Portillo CF; Serrano SM; Barrio AG; Bahsas A; Amaro-Luis J
Arch Pharm (Weinheim); 2005 Jan; 338(1):32-7. PubMed ID: 15674802
[TBL] [Abstract][Full Text] [Related]
18. Antiparasitic activity of furanyl N-acylhydrazone derivatives against Trichomonas vaginalis: in vitro and in silico analyses.
Alves MSD; das Neves RN; Sena-Lopes Â; Domingues M; Casaril AM; Segatto NV; Nogueira TCM; de Souza MVN; Savegnago L; Seixas FK; Collares T; Borsuk S
Parasit Vectors; 2020 Feb; 13(1):59. PubMed ID: 32046788
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in silico trichomonacidal activity of 2,8-bis(trifluoromethyl) quinoline analogs against Trichomonas vaginalis.
Alves MSD; Sena-Lopes Â; das Neves RN; Casaril AM; Domingues M; Birmann PT; da Silva ET; de Souza MVN; Savegnago L; Borsuk S
Parasitol Res; 2022 Sep; 121(9):2697-2711. PubMed ID: 35857093
[TBL] [Abstract][Full Text] [Related]
20. Recent Advances in the Development of Triose Phosphate Isomerase Inhibitors as Antiprotozoal Agents.
Vázquez-Jiménez LK; Moreno-Herrera A; Juárez-Saldivar A; González-González A; Ortiz-Pérez E; Paz-González AD; Palos I; Ramírez-Moreno E; Rivera G
Curr Med Chem; 2022; 29(14):2504-2529. PubMed ID: 34517794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
